Skip to main content
Log in

Hirayama-Syndrom in Deutschland

Fallberichte und Literaturübersicht

Hirayama disease in Germany

Case reports and review of the literature

  • Übersichten
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Das Hirayama-Syndrom ist eine in Europa seltene, juvenile, benigne, da zunächst langsam progrediente und nach wenigen Jahren stationäre Amyotrophie der distalen oberen Extremitäten mit Beteiligung meist der C7- bis Th1-innervierten Muskeln gewöhnlich einer Seite. Die Pathogenese dieser meistens sporadisch auftretenden Erkrankung ist bislang noch nicht gesichert. Am besten ist die Hypothese einer zervikalen Flexionsmyelopathie mit mechanisch-ischämischer Schädigung der Vorderhornneurone etabliert, daneben werden neurodegenerative und autoimmune Genesen diskutiert. Betroffen sind in der Regel junge Männer asiatischer Provenienz. Wir beschreiben hier drei deutsche Patienten kaukasischer Herkunft, bei denen nach Ausschluss relevanter Differenzialdiagnosen ein Hirayama-Syndrom diagnostiziert wurde und geben anschließend eine Literaturübersicht über das Krankheitsbild.

Summary

Hirayama disease is a juvenile benign distal upper limb muscular atrophy rarely observed in Europe, usually monomelic involving C7–Th1 innervated muscles. It is characterized by insidious onset and a self-limited course within a few years. The pathogenesis of this mostly sporadic disease is not fully clarified. Cervical flexion myelopathy with mechanical ischemic damage of spinal motoneurons is the best established pathogenetic hypothesis, but neurodegenerative and autoimmune causes are also debated. Typically, young men of Asian origin are affected. Here we describe three German Caucasian patients with Hirayama disease and provide an up-to-date review of the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Ammendola A, Gallo A, Iannaccone T et al (2008) Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy. Neurol Sci 29:303–311

    Article  PubMed  Google Scholar 

  2. Andreadou E, Christodoulou K, Manta P et al (2009) Familial asymmetric distal upper limb amyotrophy (Hirayama disease): report of a Greek family. Neurologist 15:156–160

    Article  PubMed  Google Scholar 

  3. Arrese I, Rivas JJ, Esteban J et al (2009) A case of Hirayama disease treated with laminectomy and duraplasty without spinal fusion. Neurocirugia (Asturias, Spain) 20:555–558

    Google Scholar 

  4. Baba Y, Nakajima M, Utsunomiya H et al (2004) Magnetic resonance imaging of thoracic epidural venous dilation in Hirayama disease. Neurology 62:1426–1428

    PubMed  CAS  Google Scholar 

  5. Blumen SC, Drory VE, Sadeh M et al (2010) Mutational analysis of glycyl-tRNA synthetase (GARS) gene in Hirayama disease. Amyotroph Lateral Scler 11:237–239

    Article  PubMed  CAS  Google Scholar 

  6. Chen CJ, Hsu HL, Tseng YC et al (2004) Hirayama flexion myelopathy: neutral-position MR imaging findings – importance of loss of attachment. Radiology 231:39–44

    Article  PubMed  Google Scholar 

  7. Chen TH, Hung CH, Hsieh TJ et al (2010) Symmetric atrophy of bilateral distal upper extremities and hyperIgEaemia in a male adolescent with Hirayama disease. J Child Neurol 25:371–374

    Article  PubMed  Google Scholar 

  8. Ciceri EF, Chiapparini L, Erbetta A et al (2010) Angiographically proven cervical venous engorgement: a possible concurrent cause in the pathophysiology of Hirayama’s myelopathy. Neurol Sci 31:845–848

    Article  PubMed  Google Scholar 

  9. Drooz RB (1947) Benign focal amyotrophy. Arch Neurol Psychiatry 58:498–505

    PubMed  CAS  Google Scholar 

  10. Elsheikh B, Kissel JT, Christoforidis G et al (2009) Spinal angiography and epidural venography in juvenile muscular atrophy of the distal arm „Hirayama disease“. Muscle Nerve 40:206–212

    Article  PubMed  Google Scholar 

  11. Fujimoto Y, Oka S, Tanaka N et al (2002) Pathophysiology and treatment for cervical flexion myelopathy. Eur Spine J 11:276–285

    Article  PubMed  Google Scholar 

  12. Gamez J, Also E, Alias L et al (2007) Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama’s disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients. Clin Neurol Neurosurg 109:844–848

    Article  PubMed  Google Scholar 

  13. Gouri-Devi M, Nalini A (2003) Long-term follow-up of 44 patients with brachial monomelic amyotrophy. Acta Neurol Scand 107:215–220

    Article  Google Scholar 

  14. Gouri-Devi M, Suresh TG, Shankar SK (1984) Monomelic amyotrophy. Arch Neurol 41:388–394

    Article  Google Scholar 

  15. Gücüyener K, Aysun S, Topaloglu H et al (1991) Monomelic amyotrophy in siblings. Pediatr Neurol 7:220–222

    Article  PubMed  Google Scholar 

  16. Guglielmo GD, Brahe C, Di Muzio A et al (1996) Benign monomelic amyotrophies of upper and lower limb are not associated to deletions of survival motor neuron gene. J Neurol Sci 141:111–113

    Article  PubMed  CAS  Google Scholar 

  17. Hirayama K (2000) Juvenile muscular atrophy of distal upper extremity (Hirayama disease). Intern Med (Tokyo) 39:283–290

    Google Scholar 

  18. Hirayama K (1959) Juvenile muscular atrophy of unilateral upper extremity a new clinical entity. Psychiatr Neurol Jpn 61:2190–2197

    Google Scholar 

  19. Hirayama K, Tokumaru Y (2000) Cervical dural sac and spinal cord in juvenile muscular atrophy of distal upper extremity. Neurology 54:1922–1926

    PubMed  CAS  Google Scholar 

  20. Hirayama K, Tomonaga M, Kitano K et al (1987) Focal cervical poliopathy causing juvenile muscular atrophy of distal upper extremity: a pathological study. J Neurol Neurosurg Psychiatry 50:285–290

    Article  PubMed  CAS  Google Scholar 

  21. Huang YC, Ro LS, Chang HS et al (2008) A clinical study of Hirayama disease in Taiwan. Muscle Nerve 37:576–582

    Article  PubMed  Google Scholar 

  22. Imai T, Shizukawa H, Nakanishi K et al (2000) Hyperexcitability of cervical motor neurons during neck flexion in patients with Hirayama disease. Electromyogr Clin Neurophysiol 40:11–15

    PubMed  CAS  Google Scholar 

  23. Ito S, Kuwabara S, Fukutake T et al (2005) HyperIgEaemia in patients with juvenile muscular atrophy of the distal upper extremity (Hirayama disease). J Neurol Neurosurg Psychiatry 76:132–134

    Article  PubMed  CAS  Google Scholar 

  24. Iwasaki Y, Tashiro K, Kikuchi S et al (1987) Cervical flexion myelopathy: a „tight dural canal mechanism“. Case report. J Neurosurg 66:935–937

    Article  PubMed  CAS  Google Scholar 

  25. Kajikawa H, Kokubo Y, Taniguchi A et al (2009) Juvenile muscular atrophy of the distal upper extremity (hirayama disease) in two lanky look-alike brothers. Neurologist 15:220–222

    Article  PubMed  Google Scholar 

  26. Kiguchi S, Tashiro K (2003) Juvenile muscular atrophy of distal upper extremity (Hirayama’s disease). In: Jones HR, De Vivo DC, Darras BT (Hrsg) Neuromuscular disorders of infancy, childhood, and adolescence: a clinician’s approach. Butterworth Heinemann, Philadelphia, S 167–181

  27. Kira J, Ochi H (2001) Juvenile muscular atrophy of the distal upper limb (Hirayama disease) associated with atopy. J Neurol Neurosurg Psychiatry 70:798–801

    Article  PubMed  CAS  Google Scholar 

  28. Kohno M, Takahashi H, Ide K et al (1999) Surgical treatment for patients with cervical flexion myelopathy. J Neurosurg 91:33–42

    Article  PubMed  CAS  Google Scholar 

  29. Konno S, Goto S, Murakami M et al (1997) Juvenile amyotrophy of the distal upper extremity: pathologic findings of the dura mater and surgical management. Spine (Phila Pa 1976) 22:486–492

    Google Scholar 

  30. Lai V, Wong YC, Poon Wl et al (2010) Forward shifting of posterior dural sac during flexion cervical magnetic resonance imaging in Hirayama disease: An initial study on normal subjects compared to patients with Hirayama disease. Eur J Radiol [Epub ahead of print]

  31. Misra UK, Kalita J (1995) Central motor conduction in Hirayama disease. Electroencephalogr Clin Neurophysiol 97:73–76

    Article  PubMed  CAS  Google Scholar 

  32. Misra UK, Kalita J, Mishra VN et al (2005) A clinical, magnetic resonance imaging, and survival motor neuron gene deletion study of Hirayama disease. Arch Neurol 62:120–123

    Article  PubMed  CAS  Google Scholar 

  33. Misra UK, Kalita J, Mishra VN et al (2006) Effect of neck flexion on F wave, somatosensory evoked potentials, and magnetic resonance imaging in Hirayama disease. J Neurol Neurosurg Psychiatry 77:695–698

    Article  PubMed  CAS  Google Scholar 

  34. Nalini A, Lokesh L, Ratnavalli E (2004) Familial monomelic amyotrophy a case report from India. J Neurol Sci 220:95–98

    Article  PubMed  CAS  Google Scholar 

  35. Ochi H, Murai H, Osoegawa M et al (2003) Juvenile muscular atrophy of distal upper extremity associated with airway allergy: two cases successfully treated by plasma exchange. J Neurol Sci 206:109–114

    Article  PubMed  Google Scholar 

  36. Patel TR, Chiocca EA, Freimer ML et al (2009) Lack of epidural pressure change with neck flexion in a patient with Hirayama disease: case report. Neurosurgery 64:E1196–E1197

    Article  PubMed  Google Scholar 

  37. Polo A, Curro‘ Dossi M, Fiaschi A et al (2003) Peripheral and segmental spinal abnormalities of median and ulnar somatosensory evoked potentials in Hirayama’s disease. J Neurol Neurosurg Psychiatry 74:627–632

    Article  PubMed  CAS  Google Scholar 

  38. Pradhan S (2009) Bilaterally symmetric form of Hirayama disease. Neurology 72:2083–2089

    Article  PubMed  Google Scholar 

  39. Pradhan S, Gupta RK (1997) Magnetic resonance imaging in juvenile asymmetric segmental spinal muscular atrophy. J Neurol Sci 146:133–138

    Article  PubMed  CAS  Google Scholar 

  40. Restuccia D, Rubino M, Valeriani M et al (2003) Cervical cord dysfunction during neck flexion in Hirayama’s disease. Neurology 60:1980–1983

    PubMed  CAS  Google Scholar 

  41. Robberecht W, Aguirre T, Van Den Bosch L et al (1997) Familial juvenile focal amyotrophy of the upper extremity (Hirayama disease). Superoxide dismutase 1 genotype and activity. Arch Neurol 54:46–50

    Article  PubMed  CAS  Google Scholar 

  42. Schlegel U, Jerusalem F, Tackmann W et al (1987) Benign juvenile focal muscular atrophy of upper extremities – a familial case. J Neurol Sci 80:351–353

    Article  PubMed  CAS  Google Scholar 

  43. Tanaka M, Ishizu T, Ochi H et al (2008) Intrathecal upregulation of IFN-gamma and MIP-1beta in juvenile muscular atrophy of the distal upper extremity. J Neurol Sci 275:74–77

    Article  PubMed  CAS  Google Scholar 

  44. Tashiro K, Kikuchi S, Itoyama Y et al (2006) Nationwide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan. Amyotroph Lateral Scler 7:38–45

    Article  PubMed  Google Scholar 

  45. Tokumaru Y, Hirayama K (2001) Cervical collar therapy for juvenile muscular atrophy of distal upper extremity (Hirayama disease) results from 38 cases. Clin Neurol (Rinsho shinkeigaku) 41:173–178

    Google Scholar 

  46. Toma S, Shiozawa Z (1995) Amyotrophic cervical myelopathy in adolescence. J Neurol Neurosurg Psychiatry 58:56–64

    Article  PubMed  CAS  Google Scholar 

  47. Van Den Berg-Vos RM, Visser J, Franssen H et al (2003) Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain 126:1036–1047

    Article  Google Scholar 

  48. Willeit J, Kiechl S, Kiechl-Kohlendorfer U et al (2001) Juvenile asymmetric segmental spinal muscular atrophy (Hirayama’s disease) three cases without evidence of „flexion myelopathy“. Acta Neurol Scand 104:320–322

    Article  PubMed  CAS  Google Scholar 

  49. Yaguchi H, Takahashi I, Tashiro J et al (2007) Scapular winging as a symptom of cervical flexion myelopathy. Intern Med (Tokyo) 46:511–513

    Google Scholar 

  50. Zhou B, Chen L, Fan D et al (2010) Clinical features of Hirayama disease in mainland China. Amyotroph Lateral Scler 11:133–139

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Workshop- und Kongressreisen: Ipsen Pharma GmbH, Medtronic GmbH, Merz Pharmaceuticals GmbH, Pfizer Pharma GmbH, Pharm Allergan GmbH, Solvay Arzneimittel GmbH, TEVA. Vortragshonorar: GlaxoSmithKline.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J.-S. Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kang, JS., Jochem-Gawehn, S., Laufs, H. et al. Hirayama-Syndrom in Deutschland. Nervenarzt 82, 1264–1272 (2011). https://doi.org/10.1007/s00115-011-3320-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-011-3320-9

Schlüsselwörter

Keywords

Navigation